Yeast Infections Treatment Market Analysis Supposed to Hold a CAGR of 5.2% DuriPosted by Shrikant Gadewar on March 23rd, 2020 Market Analysis: Such yeasts are generally present in the intestine, the vagina, and on the skin. Under normal conditions, this yeast will not cause any infection, yet at times can lead to an infection in the skin, vagina, or mouth owing to several factors of which the most common include a conducive environment, unhygienic conditions, weak immune response, amid others. Along with infants, those suffering from inflammatory disorders, hypothyroidism, obesity, and diabetes are susceptible to catching this infection. Yeast infection is most common in those areas of the skin that are humid. The Yeast Infection Treatment Market is predicted to grow at a 5.2% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report. Yeast infection which is popularly known as candidiasis is a form of infection that results from different forms of yeast known as Candida. Various factors are propelling the yeast infection market growth. Some of these factors according to the Market Research Future (MRFR) report, include rising incidence of autoimmune diseases, rising geriatric population, rising cases of HIV, government support for R&D, and growing demand for antifungal drugs. Additional factors pushing market growth include growing prevalence of infections, the widespread use of antibiotics, growing awareness, availability of new treatment and medications, technological advancements in medical science, pollution and unhealthy lifestyle, and increasing investments made in research and development activities. On the contrary, side effects associated to the treatment, complications during treatments, drug resistance, and unmet clinical needs are factors that are likely to impede the yeast infection market growth over the forecast period. Key Players:
Market Segmentation:
Regional Analysis: By region, the yeast infection market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is due to the rising cases of patients suffering from immune diseases and the presence of a vast geriatric population. The yeast infection market in Europe is predicted to have the second-largest share over the forecast period. This is chiefly due to the accessibility of government support for R&D and the availability of modern treatment facilities. The yeast infection market in the APAC region is predicted to have a notable growth over the forecast period. This is owing to the growing prevalence of HIV in the region, growing awareness about yeast infections and the accessibility of new treatment methods. China, as well as India, are the key contributors in this region. The yeast infection market in the Middle East and Africa is predicted to have minimal growth over the forecast period. This is owing to a lack of awareness and limited availability and access to treatment facilities. Like it? Share it!More by this author |